JP2003514935A5 - - Google Patents

Download PDF

Info

Publication number
JP2003514935A5
JP2003514935A5 JP2001538997A JP2001538997A JP2003514935A5 JP 2003514935 A5 JP2003514935 A5 JP 2003514935A5 JP 2001538997 A JP2001538997 A JP 2001538997A JP 2001538997 A JP2001538997 A JP 2001538997A JP 2003514935 A5 JP2003514935 A5 JP 2003514935A5
Authority
JP
Japan
Prior art keywords
polymer
diallylamine
poly
formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001538997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003514935A (ja
Filing date
Publication date
Priority claimed from GBGB9927088.6A external-priority patent/GB9927088D0/en
Application filed filed Critical
Publication of JP2003514935A publication Critical patent/JP2003514935A/ja
Publication of JP2003514935A5 publication Critical patent/JP2003514935A5/ja
Pending legal-status Critical Current

Links

JP2001538997A 1999-11-17 2000-11-10 ポリ(ジアリルアミン)ポリマー類の使用 Pending JP2003514935A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9927088.6 1999-11-17
GBGB9927088.6A GB9927088D0 (en) 1999-11-17 1999-11-17 Use of poly(diallylamine) polymers
PCT/GB2000/004308 WO2001036510A2 (en) 1999-11-17 2000-11-10 Use of poly(diallylamine) polymers

Publications (2)

Publication Number Publication Date
JP2003514935A JP2003514935A (ja) 2003-04-22
JP2003514935A5 true JP2003514935A5 (enExample) 2007-12-20

Family

ID=10864611

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001538997A Pending JP2003514935A (ja) 1999-11-17 2000-11-10 ポリ(ジアリルアミン)ポリマー類の使用

Country Status (9)

Country Link
US (1) US7767229B1 (enExample)
EP (1) EP1265942B1 (enExample)
JP (1) JP2003514935A (enExample)
AT (1) ATE287911T1 (enExample)
AU (1) AU772653B2 (enExample)
CA (1) CA2391539C (enExample)
DE (1) DE60017805T2 (enExample)
GB (1) GB9927088D0 (enExample)
WO (1) WO2001036510A2 (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606016D0 (en) * 2006-03-25 2006-05-03 Ionic Polymer Solutions Ltd Quaternary ammonium compounds and their uses
GB0613013D0 (en) 2006-06-30 2006-08-09 Novel Polymer Solutions Ltd Polymeric Materials and Methods for Manufacturing Them
DE102010002141A1 (de) 2010-02-19 2011-08-25 Momentive Performance Materials GmbH, 51373 Integrale Bestrahlungseinheit
WO2012017235A1 (en) 2010-08-02 2012-02-09 Novel Polymer Solutions Limited Covered floors and methods of adhering flooring to a floor
EP2601272B8 (en) 2010-08-02 2015-02-25 Syntor Specialty Chemicals Limited Composite articles and methods of producing same
EP2601047B8 (en) 2010-08-02 2015-02-25 Syntor Specialty Chemicals Limited Methods of coating a low surface energy substrate
KR101890959B1 (ko) 2010-11-04 2018-08-22 알비레오 에이비 간질환 치료를 위한 ibat 억제제
GB201105453D0 (en) 2011-03-31 2011-05-18 Novel Polymer Solutions Ltd Window frames, structural elements for a roofed construction and methods of assembling same
US9925696B2 (en) 2011-08-18 2018-03-27 Momentive Performance Materials Gmbh Irradiation and molding unit
GB201115823D0 (en) 2011-09-13 2011-10-26 Novel Polymer Solutions Ltd Mineral processing
US10384382B2 (en) 2012-06-11 2019-08-20 Momentive Performance Materials Gmbh Process for the preparation of plastic composite molded bodies
ES2733493T3 (es) 2013-06-05 2019-11-29 Tricida Inc Polímeros de unión a protones para la administración oral
CN106659726A (zh) 2014-06-25 2017-05-10 Ea制药株式会社 固体制剂及其着色防止或着色减少方法
IL322207A (en) 2014-12-10 2025-09-01 Tricida Inc Proton-binding polymers for oral administration
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
MA44875A (fr) 2016-05-06 2019-03-13 Tricida Inc Compositions pour le traitement de troubles acido-basiques
CA3071285A1 (en) 2017-08-09 2019-02-14 Albireo Ab Cholestyramine granules, oral cholestyramine formulations and use thereof
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
WO2019090176A1 (en) 2017-11-03 2019-05-09 Tricida, Inc. Compositions for and method of treating acid-base disorders
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
CN112449637B (zh) 2018-06-05 2024-03-19 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
SG11202012151XA (en) 2018-06-20 2021-01-28 Albireo Ab Crystal modifications of odevixibat
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
MX2021008981A (es) 2019-02-06 2021-09-08 Albireo Ab Compuestos de benzotiadiazepina y su uso como moduladores del acido biliar.
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
CN114761080B (zh) 2019-12-04 2024-07-23 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
CA3158184A1 (en) 2019-12-04 2021-08-10 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
EP4069360B1 (en) 2019-12-04 2024-01-03 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
JP7696898B2 (ja) 2019-12-04 2025-06-23 アルビレオ・アクチボラグ ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
ES3002777T3 (en) 2020-08-03 2025-03-07 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
EP4243831A1 (en) 2020-11-12 2023-09-20 Albireo AB Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
EP4255565A1 (en) 2020-12-04 2023-10-11 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
TW202313579A (zh) 2021-06-03 2023-04-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE520401A (enExample) * 1952-06-03
US3957699A (en) * 1973-06-12 1976-05-18 Ici Australia Limited Process for polymerizing allylamines employing a redox initiator consisting of Fe++ or Ti+++ with H2 O2, hydroxyl amine, or hydroperoxides to form insoluble crosslinked polymers
US4121986A (en) * 1975-05-07 1978-10-24 Ici Australia Limited Process for the polymerization of polyallylamines in the presence of a mineral acid solution
JPS5747302A (en) * 1980-09-03 1982-03-18 Mitsubishi Petrochem Co Ltd Preparation of crosslinkable electrolytic polymer
JPS62257481A (ja) 1986-04-30 1987-11-10 三洋化成工業株式会社 染料固着剤
US4759923A (en) 1987-06-25 1988-07-26 Hercules Incorporated Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives
JPH021358A (ja) * 1988-03-01 1990-01-05 Sanyo Chem Ind Ltd インクジェット記録紙用薬剤
US6203785B1 (en) * 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
SG105450A1 (en) * 1998-07-02 2004-08-27 Nat Starch Chem Invest Allylated amide compounds and die attach adhesives prepared therefrom
SG85658A1 (en) * 1998-07-02 2002-01-15 Nat Starch Chem Invest Package encapsulants prepared from allylated amide compounds
GB9816167D0 (en) * 1998-07-25 1998-09-23 Secr Defence Polymer production
GB9816171D0 (en) * 1998-07-25 1998-09-23 Secr Defence Monomers and network polymers obtained therefrom

Similar Documents

Publication Publication Date Title
JP2003514935A5 (enExample)
US7767229B1 (en) Use of poly diallyamine polymers
Richmond et al. Preoperative morphine pre-empts postoperative pain
JP2004512318A5 (enExample)
JP2004509061A5 (enExample)
JP2001247459A5 (enExample)
KR19980042555A (ko) 콘디로마 아큐미나타치료제 및 치료방법
WO2001060381B1 (en) Nucleoside analogs with carboxamidine-modified bicyclic base
HUP9802339A2 (hu) Darifenacint tartalmazó gyógyászati készítmények
HUP0003131A2 (hu) Polietilénglikol/alfa-interferon konjugátumok fertőzés kezelésére
JP2023540149A (ja) 抗ウイルス化合物の製剤
JP2002525323A5 (enExample)
KR19990087477A (ko) 완충된 오르쏘 에스테르 중합체를 포함하는 약학 조성물
RU2008139195A (ru) Замещенные арилсульфанамиды как противовирусные средства
CA2373833C (en) Medicinal compositions for preventing or treating viral myocarditis
JP2001520656A (ja) 抗腫瘍剤としてのホルボールエステル類
Heller et al. Development and applications of injectable poly (ortho esters) for pain control and periodontal treatment
JP2787539B2 (ja) ウイルス性疾患の予防または治療剤
JP2005528332A5 (enExample)
JPH1036365A5 (enExample)
JP2002518506A5 (enExample)
CN1179722A (zh) 用hiv蛋白酶抑制剂indinavir和逆转录酶抑制剂3tc,以及任选的azt、ddi或ddc,对hiv感染进行组合治疗
JP2004502696A5 (enExample)
WO1998016252A1 (en) New pharmaceutical parenteral formulation of a thrombin inhibitor
JP2006083190A (ja) 手術後の悪心および嘔吐の治療のためのグラニセトロンの使用